HomeCELU • NASDAQ
Celularity Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 18.13M | 49.70% |
Operating expense | 20.26M | 51.79% |
Net income | -13.29M | -239.24% |
Net profit margin | -73.31 | -193.01% |
Earnings per share | — | — |
EBITDA | -7.60M | 11.15% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 738.00K | 225.11% |
Total assets | 132.68M | -7.79% |
Total liabilities | 123.85M | 20.32% |
Total equity | 8.84M | — |
Shares outstanding | 23.95M | — |
Price to book | 4.33 | — |
Return on assets | -18.11% | — |
Return on capital | -28.88% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -13.29M | -239.24% |
Cash from operations | 1.59M | 136.72% |
Cash from investing | -1.56M | -168.28% |
Cash from financing | 643.00K | 4,692.86% |
Net change in cash | 681.00K | 113.80% |
Free cash flow | -5.56M | 79.28% |
Previous close
$1.99
Day range
$2.00 - $2.10
Year range
$1.00 - $5.22
Market cap
48.86M USD
Avg Volume
69.80K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1998
Headquarters
Website
Employees
123